Eisai Satisfies All-Case Surveillance Requirement for Anticancer Agent Remitoro
TOKYO, May 16, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. announced today that it has received notification from Japan’s Ministry of Health, Labour, and Welfare (MHLW) that […]